Sponsor Pipeline

Changzhou Qianhong Bio-pharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06532058
Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid…		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07396337 Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke. Acute Ischemic Stroke Recruiting
Disease Areas
Stroke (1)
Get alerts when Changzhou Qianhong Bio-pharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free